Cargando…

Leveraging MYC as a therapeutic treatment option for TNBC

Detalles Bibliográficos
Autores principales:	Carey, Jason P.W., Keyomarsi, Khandan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049306/ https://www.ncbi.nlm.nih.gov/pubmed/30035166 http://dx.doi.org/10.18632/oncoscience.424

Ejemplares similares

Chemotherapy with ceramide in TNBC
por: Legembre, Patrick, et al.
Publicado: (2015)

GHRH-antagonists in TNBC
por: Engel, Jörg B.
Publicado: (2015)

PKC iota promotes ovarian tumor progression through deregulation of cyclin E
por: Nanos-Webb, Angela, et al.
Publicado: (2015)

Low-molecular-weight cyclin E: the missing link between biology and clinical outcome
por: Akli, Said, et al.
Publicado: (2004)

Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer
por: Alexander, Angela, et al.
Publicado: (2017)

Breaking the cycle: An insight into the role of ERα in eukaryotic cell cycles
por: Moghadam, Sonia Javan, et al.
Publicado: (2011)

TNBC Therapeutics Based on Combination of Fusarochromanone with EGFR Inhibitors
por: Carroll, Natalie, et al.
Publicado: (2022)

Cripto-1 in TNBC
por: Castro, Nadia P, et al.
Publicado: (2015)

IMPassionate about immunotherapy for TNBC: from change, to revolution and to cure?
por: Vagia, Elena, et al.
Publicado: (2020)

Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy
por: Luen, Stephen L., et al.
Publicado: (2019)

Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target
por: Koni, Malvina, et al.
Publicado: (2022)

Support, Patience, and Expectancy: Therapeutic Options Alongside Intensified Treatments for Depression?
por: Patten, Scott B
Publicado: (2014)

Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach
por: Sarma, Phulen, et al.
Publicado: (2020)

Single-pill combinations: a therapeutic option or necessity for vascular risk treatment?
por: Katsiki, Niki, et al.
Publicado: (2013)

Mesenchymal Stromal Cells: From Therapeutic Option to Therapeutic Target
por: Stefani, Francesca Romana, et al.
Publicado: (2023)

Hemorrhagic stroke—Pathomechanisms of injury and therapeutic options
por: Chaudhary, Neeraj, et al.
Publicado: (2019)

Leprosy stigma & the relevance of emergent therapeutic options
por: Sardana, Kabir, et al.
Publicado: (2020)

The Use of Epigenetic Biomarkers as Diagnostic and Therapeutic Options
por: Zhang, Le, et al.
Publicado: (2022)

Nandrolone decanoate: new therapeutic option for telomeropathies?
por: Frieri, Camilla
Publicado: (2023)

The Landscape of Targeted Therapies in TNBC
por: Vagia, Elena, et al.
Publicado: (2020)

Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension
por: Kim, Hyung Yoon, et al.
Publicado: (2019)

An Magnetic-Targeting Nano-Diagnosis and Treatment Platform for TNBC
por: Zhang, Mengqi, et al.
Publicado: (2023)

TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy
por: Singh, Desh Deepak, et al.
Publicado: (2021)

Neural Functions Play Different Roles in Triple Negative Breast Cancer (TNBC) and non-TNBC
por: Tan, Renbo, et al.
Publicado: (2020)

The Serine Protease Inhibitor Elafin Maintains Normal Growth Control by Opposing the Mitogenic Effects of Neutrophil Elastase
por: Caruso, Joseph A., et al.
Publicado: (2014)

Therapeutic Options for the Treatment of Carbapenem-resistant Enterobacteriaceae Infections: Hope in the Times of Hype and Despair
por: Ansari, Abdul S
Publicado: (2021)

Current and Emerging Treatment Options in Sinus and Nasal Diseases: Surgical Challenges and Therapeutic Perspectives
por: Zhao, Xiao-Ying, et al.
Publicado: (2023)

Endometriosis: An Inflammatory Disease That Requires New Therapeutic Options
por: Donnez, Jacques, et al.
Publicado: (2022)

Sinonasal Cancer: Improving Classification, Stratification and Therapeutic Options
por: Hermsen, Mario A., et al.
Publicado: (2023)

Targeting MYC for triple-negative breast cancer treatment
por: Klauber-DeMore, Nancy, et al.
Publicado: (2018)

3-Bromopyruvic acid regulates glucose metabolism by targeting the c-Myc/TXNIP axis and induces mitochondria-mediated apoptosis in TNBC cells
por: Li, Jiachen, et al.
Publicado: (2022)

The Evaluation of Cytotoxic Properties from CCB-2 Sugar Complexes Against TNBC and Non-TNBC Cells
por: Jenie, Riris Istighfari, et al.
Publicado: (2021)

Leveraging digital transformation for better health in Europe
por: Kluge, Hans Henri P, et al.
Publicado: (2022)

Therapeutic options for the treatment of venous thromboembolism in case of warfarin intolerance: Effects of novel oral anticoagulants
por: Kodani, Eitaro
Publicado: (2013)

Inhibition of ERK signaling for treatment of ERRα positive TNBC
por: Musheyev, David, et al.
Publicado: (2023)

TNBC invasion: downstream of STAT3
por: Jackson, James G., et al.
Publicado: (2017)

Present and Prospective Diagnostic and Therapeutic Options for Repeated IVF Failures
por: Sadeghi, Mohammad Reza
Publicado: (2012)

Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options
por: Hrncir, Tomas
Publicado: (2022)

Metabolic vulnerabilities of MYC-induced cancer
por: Gouw, Arvin M., et al.
Publicado: (2016)

Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away?
por: Oh, Yeon-Mok
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cs076431aqu3gaau81ukdhcoe0